Kesler Norman & Wride’s iShares iBonds Dec 2022 Term Corporate ETF IBDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-167,602
Closed -$4.2M 163
2022
Q3
$4.2M Buy
167,602
+3,173
+2% +$79.3K 1.17% 25
2022
Q2
$4.11M Sell
164,429
-19,418
-11% -$486K 1.14% 27
2022
Q1
$4.6M Buy
183,847
+1,997
+1% +$50.1K 1.02% 42
2021
Q4
$4.57M Buy
181,850
+6,798
+4% +$171K 0.97% 42
2021
Q3
$4.43M Buy
175,052
+5,787
+3% +$147K 1.04% 34
2021
Q2
$4.29M Buy
169,265
+2,175
+1% +$55.3K 0.99% 39
2021
Q1
$4.25M Buy
167,090
+6,141
+4% +$157K 1.06% 32
2020
Q4
$4.12M Buy
+160,949
New +$4.12M 1.15% 31

Other funds holding IBDN

Kesler Norman & Wride's IBDN Position: Q4 2022 in Review

Kesler Norman & Wride sold out of iShares iBonds Dec 2022 Term Corporate ETF (IBDN) in Q4 2022, closing a stake of 167,602 shares — an estimated $4.2M sold.

Kesler Norman & Wride first reported a position in IBDN in Q4 2020 and held it in 8 quarters. The position peaked at $4.6M in Q1 2022. 2 funds tracked by Wall St. Rank hold IBDN as of Q4 2022.

  • Kesler Norman & Wride reported no remaining iShares iBonds Dec 2022 Term Corporate ETF position as of Q4 2022 after selling out during the quarter.
  • Kesler Norman & Wride sold 167,602 iShares iBonds Dec 2022 Term Corporate ETF shares in Q4 2022, an estimated $4.2M.
  • Kesler Norman & Wride first reported a position in iShares iBonds Dec 2022 Term Corporate ETF in Q4 2020 and held it in 8 quarters.
  • Kesler Norman & Wride's iShares iBonds Dec 2022 Term Corporate ETF position peaked at $4.6M in Q1 2022.
  • 2 funds tracked by Wall St. Rank held iShares iBonds Dec 2022 Term Corporate ETF as of Q4 2022.

Based on Kesler Norman & Wride's 13F filing for Q4 2022, filed 7 Feb 2023.